Bactericidal Effect of Synthetic Phenylalkylamides Inspired by Gibbilimbol B Against Neisseria gonorrhoeae
Molecules · 30.05.2025 · 30 (11) · 2406
DOI: 10.3390/molecules30112406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 30.05.2025. Verfasst von Larissa V F Oliveira und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Natural Sciences and Humanities, Federal University of ABC, Sao Paulo 09210-580, Brazil. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Anti-Bacterial Agents, Amides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The São Paulo Research Foundation, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
Increasing multidrug resistance in Neisseria gonorrhoeae poses a serious and escalating public health crisis. The World Health Organization has classified N. gonorrhoeae as a high-priority pathogen for developing new antimicrobials. Natural products provide a promising avenue for antimicrobial discovery, serving as direct therapeutic agents or prototypes for novel drug development. Among these, gibbilimbol B, a compound isolated from Piper malacophyllum, is particularly attractive due to its biological potential and simple structure. In this study, eight synthetic phenylalkylamides (1–8) inspired by gibbilimbol B were synthesized and evaluated for their antibacterial activity against N. gonorrhoeae. The in vitro bacterial assays revealed that these compounds exhibit notable antibacterial activity, including against resistant strains selected from the CDC/FDA antimicrobial panel (strains AR-173, AR-174, AR-187, and AR-200). All synthesized compounds demonstrated superior efficacy in killing N. gonorrhoeae compared to gibbilimbol B. Notably, compound 8 [(E)-4-chloro-N-(oct-4-en-1-yl)benzamide] showed an MBC50 of 6.25 µM, representing a four-fold improvement in bactericidal activity over the natural compound. This study represents the first exploration of gibbilimbol analogs for antibacterial applications, highlighting the novelty of the work and paving the way for the development of new antibacterial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Natural Sciences and Humanities, Federal University of ABC, Sao Paulo 09210-580, Brazil.
- Neisseria Research Laboratory, Molecular Microbiology, School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
- Laboratory of Pathophysiology, Butantan Institute, Sao Paulo 05508-040, Brazil.
ORCID-Profile: Larissa V F Oliveira, Myron Christodoulides, Joao Henrique G Lago
Förderung
- The São Paulo Research Foundation
- National Council for Scientific and Technological Development
Zitieren
APA
Oliveira, L. V. F., Tempone, A. G., Christodoulides, M., & Lago, J. H. G. (2025). Bactericidal Effect of Synthetic Phenylalkylamides Inspired by Gibbilimbol B Against Neisseria gonorrhoeae. Molecules, 30(11), 2406. https://doi.org/10.3390/molecules30112406
Vancouver
Oliveira LVF, Tempone AG, Christodoulides M, Lago JHG. Bactericidal Effect of Synthetic Phenylalkylamides Inspired by Gibbilimbol B Against Neisseria gonorrhoeae. Molecules. 2025;30(11):2406. doi:10.3390/molecules30112406
BibTeX
@article{Oliveira2025,
author = {Oliveira, Larissa V F and Tempone, Andre G and Christodoulides, Myron and Lago, Joao Henrique G},
title = {Bactericidal Effect of Synthetic Phenylalkylamides Inspired by Gibbilimbol B Against Neisseria gonorrhoeae},
journal = {Molecules},
year = {2025},
volume = {30},
number = {11},
pages = {2406},
doi = {10.3390/molecules30112406}
}
EUVIMED